Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research[1][2].
Molecular Weight:
(144.92 kDa)
Purity:
99.79
CAS Number:
[1326232-46-5]
Target:
IFNAR
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted